Breast Cancer Survivorship (eBook)
XV, 284 Seiten
Springer International Publishing (Verlag)
978-3-319-41858-2 (ISBN)
This book discusses the impact on women of the diagnosis and treatment of early breast cancer. Readers will learn about the risks of breast cancer recurrence and interventions to reduce these, such as endocrine therapy and bisphosphonate therapy, as well as the role of lifestyle factors such as diet and exercise. The long-term effects of treatment on fertility, the heart and other systems are discussed, as well the psychological burden for women who are increasingly likely to be cured from their cancer. Each chapter provides background and a practical guide in the management of women after the initial phase of diagnosis and treatment.
Authored by a multidisciplinary team this book provides all the relevant expertise as well as different perspectives, providing a holistic picture of early breast cancer consequences.
From oncologists to general practitioners as well as specialist nurses, gynaecologists, psychologists and other healthcare professionals involved in the long-term care of women with breast cancer, this book provides a timely and indispensable guide to practitioners caring for early breast cancer survivors.
Dr Ring is a consultant in medical oncology at the Royal Marsden Hospital. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at the Royal Marsden, St George's and Guy's Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research at the University of London. In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant in Medical Oncology at the Royal Marsden Hospital.
He has a specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a study which will investigate the role of aspirin in the treatment of over 3000 women with early breast cancer. He is Chair of the Committee for Clinical Research at the Royal Marsden Hospital and Institute of Cancer Research. Dr Ring has published widely in peer-reviewed journals and in 2015 edited the textbook 'Problem-solving in older cancer patients.'
He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology.
Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden and Kingston Hospitals. Appointed to The Royal Marsden Consultant body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research at the University of London.
Dr Parton is Lead Cancer Clinician in The Royal Marsden's first satellite chemotherapy unit, a joint venture with Kingston Hospital and Macmillan Cancer Support. She has chaired and taken part in groups within the London Cancer Alliance for the Breast pathway, Chemotherapy Closer to Home, Menopausal Symptoms Management and Sexuality and Consequences of Therapy. She has led on a number of projects delivering care closer to home, and the development of Acute Oncology at cancer centres and cancer units. Dr Parton has been PI to a number of national and international studies in early breast cancer, and has published in peer-reviewed international journals.
<
Dr Ring is a consultant in medical oncology at the Royal Marsden Hospital. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at the Royal Marsden, St George’s and Guy’s Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research at the University of London. In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant in Medical Oncology at the Royal Marsden Hospital. He has a specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a study which will investigate the role of aspirin in the treatment of over 3000 women with early breast cancer. He is Chair of the Committee for Clinical Research at the Royal Marsden Hospital and Institute of Cancer Research. Dr Ring has published widely in peer-reviewed journals and in 2015 edited the textbook “Problem-solving in older cancer patients.” He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology. Dr Marina Parton is a Medical Oncologist in Breast Cancer at The Royal Marsden and Kingston Hospitals. Appointed to The Royal Marsden Consultant body in 2009, she received her oncology training at The Royal Marsden and carried out her research in neoadjuvant therapy in breast cancer as part of a MD at The Institute of Cancer Research at the University of London. Dr Parton is Lead Cancer Clinician in The Royal Marsden's first satellite chemotherapy unit, a joint venture with Kingston Hospital and Macmillan Cancer Support. She has chaired and taken part in groups within the London Cancer Alliance for the Breast pathway, Chemotherapy Closer to Home, Menopausal Symptoms Management and Sexuality and Consequences of Therapy. She has led on a number of projects delivering care closer to home, and the development of Acute Oncology at cancer centres and cancer units. Dr Parton has been PI to a number of national and international studies in early breast cancer, and has published in peer-reviewed international journals.
1. Introduction
David Okonji and Alistair Ring
PART 1: DISEASE RECURRENCE
2 Predicting Risk of Disease Recurrence
Belinda Yeo
3 Detection of Recurrence: Clinical Follow-Up
Anne Mc Loughlin and Nicola Roche
4 Detection of Recurrence: Imaging Strategies
Kate Downey and Steven Allen
5 Follow Up of Patients with Germline Mutations in High Risk Predisposition Genes
Zoe Kemp
PART 2: INTERVENTIONS TO REDUCE RISK OF RECURRENCE
6 Endocrine Therapy
Stefania Redana
7 Systemic Therapies to Reduce the Risk of Recurrence in Early Breast Cancer: New Strategies
Narda Chaabouni, Christos Nikolaou and Mark Harries
8 Exercise in Breast Cancer Survivors
Nawa Mustafa Amin and Alistair Ring
9 Dietary Components and Breast Cancer Survivorship
Clare Shaw
PART 3: SEQUELAE OF EARLY BREAST CANCER AND ITS TREATMENT
10 Identifying and Managing the Consequences of Treatment for Early Breast Cancer
Natalie Doyle, Nicola Cunningham, and Richard Henry
11 Managing Loco-Regional Complications of Breast Cancer Treatment
Anna M. Kirby
12 The Role of Surgery in Breast Cancer Survivors
Rachel L. O’Connell and Jennifer E. Rusby
13 Management of Menopausal Symptoms in Breast Cancer Survivors
Helen Mitchell and Anne C. Armstrong
14 Bone Health
Amy Kwan, Omar S. Din, and Matthew Winter
15 Fertility
Stuart Lavery and Georgios Christopoulos
16 Cardiotoxicity in Breast Cancer Survivors
Nilesh Pareek, Susannah Stanway, Anna M. Kirby, and Alexander Lyon
17 Second Primary Neoplasms Following a Diagnosis of Breast Cancer
Felicity Paterson, Susannah Stanway, Lone Gothard, and Navita Somaiah
18 The Effects of Breast Cancer Treatments on Cognition
Helena Harder and Valerie A. Jenkins
19 Psychological Issues in Breast Cancer Survivorship
Richard Towers
20 Fatigue in Breast Cancer Survivors
Belinda Kingston and Marta Capelan
| Erscheint lt. Verlag | 1.12.2016 |
|---|---|
| Zusatzinfo | XV, 284 p. 18 illus., 13 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Allgemeinmedizin |
| Medizin / Pharmazie ► Pflege | |
| Schlagworte | Chemotherapy • Late Effects • psycho oncology • recurrence • Sequelae |
| ISBN-10 | 3-319-41858-0 / 3319418580 |
| ISBN-13 | 978-3-319-41858-2 / 9783319418582 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 5,0 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
